Form 4: NeueHealth Director Makhzoumi Acquires Warrants
SEC Form 4
Director Mohamad Makhzoumi reports the acquisition of warrants for NeueHealth, Inc. through indirect ownership.
Summary
- Mohamad Makhzoumi, a director of NeueHealth, Inc., has reported the acquisition of warrants to purchase common stock.
- The transactions occurred on October 1, 2024, with the warrants priced at $0.01.
- Makhzoumi acquired 61,865 warrants each through NEA 15, NEA 16 and NEA 17, and 185,595 warrants through NEA 18 VGE.
- The warrants are exercisable between October 2, 2024, and April 30, 2029.
- Makhzoumi disclaims beneficial ownership of the securities held by NEA 15, NEA 16, NEA 17 and NEA 18 VGE, except to the extent of his pecuniary interest.
- The warrants were issued pursuant to a Warrantholders Agreement and Credit Agreement.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of warrant acquisitions, with no inherent positive or negative implications.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders such as directors or officers make transactions in their company's stock, providing transparency to investors.
Key Dates
| Date | Description |
|---|---|
| 2023-08-04 | Date of the Credit Agreement between the Issuer and the lenders thereto. |
| 2023-10-02 | Date of Incremental Amendment No. 1 to the Credit Agreement. |
| 2024-04-08 | Date of the Warrantholders Agreement between the Issuer and the holders listed on Schedule 1 thereto, and Incremental Amendment No. 2 to the Credit Agreement. |
| 2024-10-01 | Date of the warrant acquisition transaction. |
| 2024-10-02 | Date the warrants become exercisable. |
| 2029-04-30 | Expiration date of the warrants. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.